Well if you are considering it you might have to wait a year or two for clinical trial results and commercial approval. Most likely it will result in a partnership deal with an established player like Edwards.
But from a technical point of view, it ticks an awful lot of boxes. If the trial results bear this out it's probably going to be irresistible to someone.
AVR Price at posting:
$26.31 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)